Acadian Asset Management
AGIO icon

Acadian Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History

Acadian Asset Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31K Sell
876
-4,983
-85% -$151K ﹤0.01% 1894
2026
Q1 		$196K Buy
+5,859
New +$166K ﹤0.01% 1594
2025
Q2 		– Sell
-4,544
Closed -$133K – 1645
2025
Q1 		$133K Buy
+4,544
New +$151K ﹤0.01% 1310
2024
Q3 		– Sell
-864
Closed -$37K – 2060
2024
Q2 		$37K Buy
+864
New +$31.2K ﹤0.01% 1627
2021
Q3 		– Sell
-1,686
Closed -$93K – 1696
2021
Q2 		$93K Buy
+1,686
New +$94.3K ﹤0.01% 1644
2020
Q3 		– Sell
-1,233
Closed -$66K – 2151
2020
Q2 		$66K Buy
+1,233
New +$57.1K ﹤0.01% 1836
2017
Q1 		– Sell
-2,526
Closed -$105K – 1544
2016
Q4 		$105K Buy
+2,526
New +$133K ﹤0.01% 1096

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Acadian Asset Management's AGIO Position: Q2 2026 in Review

Acadian Asset Management reduced its Agios Pharmaceuticals (AGIO) stake by 85% in Q2 2026, selling an estimated $151K and leaving 876 shares worth $31K. The position accounts for ﹤0.01% of the portfolio, ranked #1894.

Acadian Asset Management first reported a position in AGIO in Q4 2016 and has held it in 7 quarters since. The position peaked at $196K in Q1 2026. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Acadian Asset Management held 876 shares of Agios Pharmaceuticals worth $31K as of Q2 2026.
  • Acadian Asset Management sold 4,983 Agios Pharmaceuticals shares in Q2 2026, an estimated $151K.
  • Agios Pharmaceuticals made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1894 holding.
  • Acadian Asset Management first reported a position in Agios Pharmaceuticals in Q4 2016 and has held it in 7 quarters since.
  • Acadian Asset Management's Agios Pharmaceuticals position peaked at $196K in Q1 2026.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.